Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sofosbuvir, ledipasvir and ribavirin give high cure rates in drug users with hepatitis C

Nov. 17, 2016

Japanese researchers develop antimalarial agents

Nov. 17, 2016

FDA issues complete response letter for Heplisav-B BLA

Nov. 15, 2016

Katholieke Universiteit Leuven discloses PMDT nucleoside phosphonates

Nov. 15, 2016

Texas A&M University patents antimycobacterial agents

Nov. 15, 2016

EMA gives positive opinion on Gilead's MAA for Vemlidy

Nov. 14, 2016

Assembly Biosciences starts phase Ia/Ib trial of ABI-H0731

Nov. 11, 2016

FDA approves Vemlidy to treat chronic HBV infection

Nov. 11, 2016

FDA places clinical hold on Heparc-2004 study of ARC-520

Nov. 9, 2016

Positive interim data from an ongoing early clinical trial of CC-31244

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...